• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Postoperative pleural effusion after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer patients: predictive role of preoperative albumin levels, diaphragmatic disease involvement and preoperative pleural effusion.

作者信息

Iavazzo Christos, Spiliotis John

机构信息

Department of Gynecological Oncology, Metaxa Cancer Hospital, Piraeus, Greece.

Department of Surgical Oncology and HIPEC, Athens Medical Centre, Athens, Greece; Department of Surgical Oncology and HIPEC, European Interbalkan Medical Centre, Thessaloniki, Greece.

出版信息

Ann Palliat Med. 2021 Aug;10(8):9328-9329. doi: 10.21037/apm-21-1527. Epub 2021 Jul 29.

DOI:10.21037/apm-21-1527
PMID:34328009
Abstract
摘要

相似文献

1
Postoperative pleural effusion after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer patients: predictive role of preoperative albumin levels, diaphragmatic disease involvement and preoperative pleural effusion.
Ann Palliat Med. 2021 Aug;10(8):9328-9329. doi: 10.21037/apm-21-1527. Epub 2021 Jul 29.
2
Risk factors of pleural effusion after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in late-stage and recurrent ovarian cancer.晚期和复发性卵巢癌细胞减灭术和腹腔热灌注化疗后胸腔积液的风险因素。
Ann Palliat Med. 2021 Jan;10(1):385-391. doi: 10.21037/apm-20-2334.
3
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.接受细胞减灭术和腹腔内热化疗治疗的晚期和复发性上皮性卵巢癌女性的复发模式。
Gynecol Oncol. 2021 May;161(2):389-395. doi: 10.1016/j.ygyno.2021.01.039. Epub 2021 Feb 5.
4
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.识别膈肌细胞减灭术和术中高热腹腔内化疗后呼吸并发症的发生率。
Clin Transl Oncol. 2020 Jun;22(6):852-859. doi: 10.1007/s12094-019-02195-8. Epub 2019 Aug 7.
5
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.原发性细胞减灭术联合或不联合腹腔热灌注化疗（HIPEC）治疗国际妇产科联盟（FIGO）分期 III 期上皮性卵巢癌：OVHIPEC-2，一项 III 期随机临床试验。
Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23.
6
Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer.III 期卵巢癌患者接受间歇肿瘤细胞减灭术联合或不联合腹腔热灌注化疗（HIPEC）后的健康相关生活质量。
Eur J Surg Oncol. 2021 Jan;47(1):101-107. doi: 10.1016/j.ejso.2019.05.006. Epub 2019 May 13.
7
Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).老年卵巢癌患者行细胞减灭术加腹腔热灌注化疗（CRS/HIPEC）的治疗结果。
Ann Surg Oncol. 2021 Aug;28(8):4655-4666. doi: 10.1245/s10434-020-09415-4. Epub 2021 Jan 3.
8
Feasibility of diaphragmatic interventions in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A 20-year experience.腹腔热灌注化疗治疗腹膜转移癌的细胞减灭术中膈肌干预的可行性：20 年经验。
Eur J Surg Oncol. 2021 Jan;47(1):143-148. doi: 10.1016/j.ejso.2020.08.016. Epub 2020 Aug 26.
9
Diaphragmatic Peritonectomy and Full-Thickness Resection in CRS/HIPEC May Allow Higher Completeness of Cytoreduction Rates with a Low Rate of Respiratory Complications.CRS/HIPEC 术中膈肌腹膜切除术和全层切除术可提高细胞减灭术的完全性切除率，且呼吸并发症发生率较低。
Ann Surg Oncol. 2021 Aug;28(8):4676-4682. doi: 10.1245/s10434-020-09505-3. Epub 2021 Jan 6.
10
Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.腹腔内热灌注化疗联合细胞减灭术的适应证：临床实践指南。
Curr Oncol. 2020 Jun;27(3):146-154. doi: 10.3747/co.27.6033. Epub 2020 Jun 1.